Kintara Therapeutics Price on May 24, 2024

KTRADelisted Stock  USD 6.30  0.14  2.17%   
If you're considering investing in Kintara Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kintara Therapeutics stands at 6.30, as last reported on the 16th of December 2024, with the highest price reaching 7.93 and the lowest price hitting 5.61 during the day. At this point, Kintara Therapeutics is risky. Kintara Therapeutics has Sharpe Ratio of 0.0058, which conveys that the firm had a 0.0058% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Kintara Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Kintara Therapeutics' Mean Deviation of 5.18, standard deviation of 6.76, and Risk Adjusted Performance of (0.04) to check out if the risk estimate we provide is consistent with the expected return of 0.0448%.
  
Kintara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0058

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsKTRA

Estimated Market Risk

 7.76
  actual daily
69
69% of assets are less volatile

Expected Return

 0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Kintara Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kintara Therapeutics by adding Kintara Therapeutics to a well-diversified portfolio.

Related Headline

Lumos Pharma Headline on 24th of May 2024

Filed transaction by Lumos Pharma Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Kintara Therapeutics Valuation on May 24, 2024

It is possible to determine the worth of Kintara Therapeutics on a given historical date. On May 24, 2024 Kintara was worth 5.88 at the beginning of the trading date compared to the closed value of 5.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kintara Therapeutics stock. Still, in general, we apply an absolute valuation method to find Kintara Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kintara Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kintara Therapeutics' related companies.
 Open High Low Close Volume
  6.60    6.97    5.33    5.50    10,376,913  
05/24/2024
  5.88    5.95    5.28    5.88    10,867,329  
  6.65    7.42    5.85    6.58    28,920,848  
Backtest Kintara Therapeutics  |  Kintara Therapeutics History  |  Kintara Therapeutics Valuation   PreviousNext  
Open Value
5.88
5.88
Closing Value
29.16
Upside

Kintara Therapeutics Trading Date Momentum on May 24, 2024

On May 28 2024 Kintara Therapeutics was traded for  6.58  at the closing time. The top price for the day was 7.42  and the lowest listed price was  5.85 . The trading volume for the day was 28.9 M. The trading history from May 28, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 11.90% . The trading delta at closing time against the current closing price is 104.76% .

Kintara Therapeutics Fundamentals Correlations and Trends

By evaluating Kintara Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kintara Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kintara financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Kintara Therapeutics Stock history

Kintara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kintara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kintara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kintara Therapeutics stock prices may prove useful in developing a viable investing in Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California. Kintara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Kintara Therapeutics Stock Technical Analysis

Kintara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Kintara Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kintara Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Kintara Therapeutics Period Price Range

Low
December 16, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Kintara Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Kintara Therapeutics December 16, 2024 Market Strength

Market strength indicators help investors to evaluate how Kintara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kintara Therapeutics shares will generate the highest return on investment. By undertsting and applying Kintara Therapeutics stock market strength indicators, traders can identify Kintara Therapeutics entry and exit signals to maximize returns

Kintara Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Kintara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Kintara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kintara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Kintara Stock

If you are still planning to invest in Kintara Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kintara Therapeutics' history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities